Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials
Overview of attention for article published in Annals of the Rheumatic Diseases, March 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
Good Attention Score compared to outputs of the same age and source (71st percentile)
Mentioned by
- news
- 2 news outlets
- 10 X users
- patent
- 1 patent
- 1 Redditor
- guideline
- 1 clinical guideline source
- podcasts
- 1 podcast
Readers on
- mendeley
- 124 Mendeley